Recordati
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Recordati
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.
/ 
Frequently asked questions
To buy Recordati stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Recordati by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Recordati is RECI:xmil. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Recordati has its primary listing on Borsa Italiana/Milan Stock Exchange. You can trade Recordati with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Recordati is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Recordati as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Recordati.